Forecast Bio, Inc.
PrivateLast Round
Accelerator
Mar 13, 2026
Total Funding Raised
$100,000
Company Overview
Forecast Bio, Inc. is a biotechnology company developing an AI-powered preclinical platform that links cellular neurobiology to mental health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Workflow Automation, ML Platforms, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forecast Bio, Inc. Comparables
Compare Forecast Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eratos Therapeutics | 83% | |
| Neuroblox | 80% | |
| OccamzRazor | 78% | |
Forecast Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 13, 2026 | ||||
| Accelerator | Feb 9, 2026 | ||||
| Seed | Jul 15, 2025 |
Forecast Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Accelerator |
| One Mind | Accelerator |
| One Mind Accelerator | Seed |
| The Venture Collective | Accelerator |
| XEIA Venture Partners | Seed |
Forecast Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Forecast Bio, Inc.'s valuation, stock price, and market status.